Latest Commercialization News

Livium and Mineral Resources have agreed to extend their joint development agreement, funding additional optimisation activities for the LieNA® lithium extraction technology and setting the stage for a 50/50 joint venture.

Invictus Energy has successfully renewed its SG 4571 licence in Zimbabwe’s Cabora Bassa Basin for an additional three years, enabling continued exploration and development at the Mukuyu gas discovery.

4DMedical has landed a paid pilot contract with the US Department of Defense to deploy its CT:VQ™ lung imaging technology on active-duty personnel, marking a significant step before FDA submission and spotlighting a billion-dollar market opportunity.

Pacific Edge faces a significant Medicare reimbursement setback as Novitas finalizes a non-coverage decision for its Cxbladder tests, prompting the company to activate legal challenges and operational restructuring.

Titomic Limited has appointed Jim Simpson as Managing Director, consolidating leadership as the company accelerates its expansion in the US additive manufacturing market.

AuKing Mining has granted Resource Mining Corporation an option to acquire its Saudi Arabia joint venture interests, marking a strategic pivot towards its Cloncurry Project.

Helios Energy has engaged Houston-based W.D. Von Gonten Engineering to apply advanced geological and engineering expertise to its flagship Presidio Project in West Texas, signalling a strategic push to unlock its full potential.

Greenvale Energy has secured a $1.176 million R&D rebate, enabling the launch of Test Program 6 on its Alpha Project to optimize processing conditions ahead of bulk sample production.

Galan Lithium has secured the full Phase 2 mining permit for its Hombre Muerto West project, enabling a production scale-up to 21,000 tonnes per annum of lithium carbonate equivalent. Positioned in the lowest cost quartile, this milestone cements Galan’s role as a key player in the global lithium market.

EBR Systems has announced a rescheduling of the FDA Pre-Approval Inspection for its wireless cardiac pacing device to January 14, 2025, while maintaining its regulatory approval timeline for Q1 2025 and a commercial launch later in the year.